Search results
Biotech startup raises $190 million to focus on new approach to heart attack, stroke and more - San...
The Business Journals· 2 days agoA serial biotech entrepreneur, a longtime UCSF researcher, a shelved Big Pharma drug and $190...
2023 Valedictorian, Salutatorian Announced By Byram Hills High School
Daily Voice· 5 days agoIn an announcement on Wednesday, June 12, Byram Hills High School revealed its valedictorian and...
Diana Taurasi says she'll 'always' wear '90s-style shorts
The Arizona Republic· 3 days agoDiana Taurasi is about to start showing some skin, but that doesn’t mean she’s about to start...
Equities Research Analysts’ Price Target Changes for June 17th (ACN, AMAT, AMH, ARM, ASML, AVB,...
ETF DAILY NEWS· 3 days agoEquities Research Analysts’ price target changes for Monday, June 17th: Accenture (NYSE:ACN) had its...
Permanent Injunction Issued Preventing Launch of EYLEA® Biosimilar Yesafili™ | JD Supra
JD Supra· 7 days agoOn June 11, 2024, the Court in Case No. 1:22-cv-00061 (N.D.W. Va.) / MDL 1:24-md-03103 (N.D.W. Va.) issued a permanent injunction against the launch...
A Surprise Big Name Enters The Weight-Loss Melee
Investor's Business Daily· 5 days agoEvercore ISI analyst Umer Raffat said Gilead Sciences (GILD) hasn't been hyping the potential rival to Eli Lilly (LLY) and Structure Therapeutics (GPCR)....
Gateway - The Root
The Root· 2 days agoTexas Gov. Greg Abbott has tested positive for COVID-19, and I’m sure we all saw this coming. According to CNN, Abbott’s office made a statement on Tuesday that said the Republican governor ...
Biotech With 345% Run Posts A 'Clear Win' In Cancer Treatment
Investor's Business Daily· 2 days agoThe company tested its treatment, dubbed NX-5948, in patients with relapsed or refractory forms of...
Gateway - Quartz
Quartz· 2 days agoViking Therapeutics stock jumped 25% to $87 per share on Tuesday after the pharmaceutical company released promising clinical trial results for its experimental weight loss pill. It’s the latest ...
Stereotactic Radiotherapy Reduces Use of Anti-VEGF Therapy in Neovascular AMD
MedPage Today· 6 days agoStereotactic radiotherapy (SRT) for neovascular age-related macular degeneration (nAMD) reduced the...
